Viewing Study NCT05064306


Ignite Creation Date: 2025-12-26 @ 4:04 PM
Ignite Modification Date: 2025-12-26 @ 4:04 PM
Study NCT ID: NCT05064306
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2025-08-01
First Post: 2021-09-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: 131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module